AMLX
Price
$5.21
Change
+$0.14 (+2.77%)
Updated
Apr 24, 02:13 PM (EDT)
Capitalization
435.92M
14 days until earnings call
ATYR
Price
$3.42
Change
-$0.10 (-2.84%)
Updated
Apr 24, 02:17 PM (EDT)
Capitalization
311.01M
13 days until earnings call
Ad is loading...

AMLX vs ATYR

Header iconAMLX vs ATYR Comparison
Open Charts AMLX vs ATYRBanner chart's image
Amylyx Pharmaceuticals
Price$5.21
Change+$0.14 (+2.77%)
Volume$2.1K
Capitalization435.92M
aTyr Pharma
Price$3.42
Change-$0.10 (-2.84%)
Volume$629
Capitalization311.01M
AMLX vs ATYR Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ATYR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and ATYR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AMLX: $5.06 vs. ATYR: $3.50)
Brand notoriety: AMLX and ATYR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 132% vs. ATYR: 83%
Market capitalization -- AMLX: $435.92M vs. ATYR: $311.01M
AMLX [@Biotechnology] is valued at $435.92M. ATYR’s [@Biotechnology] market capitalization is $311.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileATYR’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ATYR’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while ATYR’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • ATYR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AMLX and ATYR are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а +32.46% price change this week, while ATYR (@Biotechnology) price change was +15.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

ATYR is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($436M) has a higher market cap than ATYR($311M). AMLX YTD gains are higher at: 33.862 vs. ATYR (-3.315). ATYR has higher annual earnings (EBITDA): -66.37M vs. AMLX (-290.98M). AMLX has more cash in the bank: 177M vs. ATYR (72.1M). AMLX has less debt than ATYR: AMLX (1.98M) vs ATYR (13.3M). AMLX has higher revenues than ATYR: AMLX (87.4M) vs ATYR (235K).
AMLXATYRAMLX / ATYR
Capitalization436M311M140%
EBITDA-290.98M-66.37M438%
Gain YTD33.862-3.315-1,022%
P/E Ratio2.69N/A-
Revenue87.4M235K37,191%
Total Cash177M72.1M245%
Total Debt1.98M13.3M15%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXATYR
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 21 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKMCX38.06N/A
N/A
Fidelity Mid-Cap Stock K
TIMVX16.10N/A
N/A
Nuveen Mid Cap Value R6
EQNVX19.96N/A
N/A
MFS Equity Income R6
TGPEX9.85N/A
N/A
T. Rowe Price Global Impact Equity Inv
ASCYX8.62N/A
N/A
Alger Small Cap Growth Y

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+2.85%
XOMAO - AMLX
68%
Closely correlated
+0.18%
IKNA - AMLX
54%
Loosely correlated
+1.68%
XOMAP - AMLX
51%
Loosely correlated
-0.49%
RGNX - AMLX
46%
Loosely correlated
+13.43%
PRME - AMLX
45%
Loosely correlated
+4.14%
More

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+0.86%
MGTX - ATYR
45%
Loosely correlated
+3.51%
NTLA - ATYR
39%
Loosely correlated
-2.65%
CRNX - ATYR
37%
Loosely correlated
+3.55%
AMLX - ATYR
36%
Loosely correlated
+2.85%
SLDB - ATYR
36%
Loosely correlated
+3.50%
More